His research focuses on the pathogenetic mechanisms in acute lymphoblastic leukemia and exploring tumor heterogeneity in B-cell lymphoma, drawing on his expertise in hematology, hematopathology, leukemia, lymphoma, and Notch signaling. Currently, his research is supported by funding from CIHR, the Leukemia and Lymphoma Society of Canada, and two program project grants through the Terry Fox Research Institute.